BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2003
View Archived Issues
Genome Therapeutics and Wyeth extend osteoporosis research alliance
Read More
Manufacturing and supply agreement signed for Genasense
Read More
Metformin XT NDA submitted for type 2 diabetes
Read More
Endo submits NDA for extended-release oxymorphone
Read More
Zyvox approved for bacterial infections in infants and children
Read More
CAT and Xoma enter crosslicensing agreement for antibody technologies
Read More
Indevus looks back at fiscal 2002
Read More
Potent, nonpeptide CCK1 receptor antagonist developed by Italian scientists
Read More
Thiazolidinone CFTR channel inhibitor identified at UCSF
Read More
Zovirax approved by FDA for recurrent cold sores
Read More
sNDA filed for Seroquel in acute mania associated with bipolar disorder
Read More
Enzon and SkyePharma form technology alliance
Read More
Additional thielavins identified as glucose-6-phosphatase inhibitors at Pfizer
Read More
Celgene completes acquisition of Anthrogenesis
Read More
Furin inhibition as a new strategy for controlling infections
Read More
Final pivotal phase III trials of AC-2993 complete enrollment
Read More
Sosei obtains Japanese rights to Eligard
Read More
Medarex files IND for MDX-070
Read More
Essential Therapeutics discontinues development of ETRX-101
Read More
Excellent oral anticoagulant activity demonstrated for YM-60828 derivative
Read More
Vertex to lead development of VX-950 in restructured agreement with Lilly
Read More
Lilly designs novel estrogen receptor modulators
Read More
Leo claims guanidine-based IKK inhibitors for cancer and inflammatory disorders
Read More
Sankyo presents novel sialidase inhibitors with utility in influenza virus infections
Read More
Antagonists of migration-inhibitory factor (MIF) discovered at Avanir
Read More
New series of NK2/NK3 antagonists and their use reported by Sanofi-Synthelabo
Read More
Roche discloses mGluR5 antagonists and their use in anxiety and pain
Read More
BMS claims new antagonists of LFA-1 and Mac-1/ICAM interaction
Read More